To elucidate the mechanisms underlying TXNIP’s antitumor effects in breast cancer cells, we conducted co-immunoprecipitation and proteomic analyses that revealed calpastatin (CAST) as a novel TXNIP-interacting protein in MDA-MB-231 and HCC-1954 cells. The gene discussed is CAST; the disease is hepatocellular carcinoma.